Text Size

Endometrial Gene Expression Profile in Controlled Ovarian Stimulation Cycles With Premature Luteinization

This study has been completed.
Sponsor:
Information provided by:
Instituto Valenciano de Infertilidad, Spain
ClinicalTrials.gov Identifier:
NCT00447850
First received: March 13, 2007
Last updated: September 18, 2009
Last verified: September 2009
History of Changes
  Purpose

Previous studies have suggested that premature luteinization (PL)during controlled ovarian stimulation (COS) decreases the implantation rate due to a negative effect on the endometrium receptivity. This study aims to describe the impact on endometrial gene expression of PL in GnRH antagonist and GnRH agonist cycles.


Condition Intervention
Premature Luteinization
 Procedure: endometrial biopsy

Study Type: Interventional
Official Title: Endometrial Gene Expression Profile in Controlled Ovarian Stimulation Cycles With Premature Luteinization

Further study details as provided by Instituto Valenciano de Infertilidad, Spain:

Study Start Date: April 2007
Study Completion Date: July 2009
Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 35 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Oocyte donors
  • Age between 18-35 years old
  • BMI 18-29
  • NORMOGONADOTROPHICS
  • PROGESTERONE ≥ 1.2 ng/ml on hCG day

Exclusion Criteria:

  • PolyCystic Ovarian Syndrome (PCOS)
  • Endometriosis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00447850

Locations
Spain
Ivi Valencia
Valencia, Spain, 46015
Sponsors and Collaborators
Instituto Valenciano de Infertilidad, Spain
Investigators
Principal Investigator: Elena Labarta, MD Instituto Valenciano de la Infertilidad
  More Information

No publications provided

Responsible Party: Dr. Elena Labarta, Instituto Valenciano de Infertilidad
ClinicalTrials.gov Identifier: NCT00447850     History of Changes
Other Study ID Numbers: VLC-EL-1006- 307-2
Study First Received: March 13, 2007
Last Updated: September 18, 2009
Health Authority: Spain: Comité Ético de Investigación Clínica

Additional relevant MeSH terms:
Adenoma
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms

ClinicalTrials.gov processed this record on June 17, 2013